5-year adherence to adjuvant endocrine treatment in Dutch women with early stage breast cancer: A population-based database study (2006-2016)

CONCLUSION: Dutch 5-year AHT adherence appears to remain poor. Improving AHT adherence in HR+ breast cancer survivors is a critical medical need.PMID:37927248 | DOI:10.3233/BD-230024
Source: Breast Disease - Category: Cancer & Oncology Authors: Source Type: research